On the other hand, supplementation with CTE, alone, or in combination with BPL1® HT prevented the MetS-induced downregulation in the gene expression of the antioxidant enzyme GPX-3 (p < 0.05 for both). The gene discussed is GPX3; the disease is metabolic syndrome.